Kappa/lambda ratio as parameter for evaluation of therapy-resistant epilepsy of childhood.
In a prospective study we tested the hypothesis whether an alteration in the immunoglobulin light chain kappa and lambda is an expression of an autoimmune mechanism. We investigated 152 children (84 boys, 68 girls, age 12 months to 16 years). Immunoglobulins were analyzed by kinetic nephelometry. The patients were grouped according to clinical and laboratory parameters. A high kappa/lambda ratio caused by high concentration of the kappa-chain was found in children with therapy-resistant epilepsy. 58% showed a high kappa/lambda ratio, in 28% no distinct association was possible and in 14% false-positive results were obtained. In seizure-free children immunological markers were specific in 71%, whilst 25% could not be characterized and 4% showed false-positive results. This alteration of immunoglobulins therefore can be used as a diagnostic parameter.
Lischka
A
A
Kinderklinik Wien-Glanzing, Osterreich.
Graf
M
M
Hauser
E
E
Herkner
K R
KR
D000293:Adolescent; D000927:Anticonvulsants / Q000627:therapeutic use; D001327:Autoimmune Diseases / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology*; D002648:Child; D002675:Child, Preschool; D004827:Epilepsy / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology*; D005189:False Positive Reactions; D005260:Female; D006801:Humans; D007145:Immunoglobulin kappa-Chains / Q000097:blood*; D007146:Immunoglobulin lambda-Chains / Q000097:blood*; D007223:Infant; D008297:Male; D009391:Nephelometry and Turbidimetry; D011446:Prospective Studies
D000927:Anticonvulsants; D007145:Immunoglobulin kappa-Chains; D007146:Immunoglobulin lambda-Chains